Literature DB >> 6871149

Ophthalmic psychoneurosis: natural history.

A Karseras, S Sullivan.   

Abstract

The status of 18 patients presenting with ocular psychosomatic symptoms is reviewed 10 to 18 months after presentation. All the patients had been discharged after the examination and reassurance given at the initial interview. In 8 patients symptoms had completely ceased, but 10 patients retained their symptoms. Transitory, self-limiting symptoms were more commonly associated with anxiety and occurred in the younger patients. Persistent symptoms were more commonly associated with depression and occurred in the older patients. Pain of the eyes, face, and head is conspicuous in both groups.

Entities:  

Mesh:

Year:  1983        PMID: 6871149      PMCID: PMC1040119          DOI: 10.1136/bjo.67.8.554

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Patients with eye symptoms and no organic illness: an interdisciplinary study.

Authors:  M P Gross; S H Sloan
Journal:  Psychiatry Med       Date:  1971-10

2.  Psychosomatic ocular irritation.

Authors:  G L Adams; J T Pearlman; S H Sloan
Journal:  Am J Psychiatry       Date:  1970-10       Impact factor: 18.112

3.  Atypical facial pain and depression.

Authors:  R G Lascelles
Journal:  Br J Psychiatry       Date:  1966-07       Impact factor: 9.319

4.  Symptoms without signs in outpatients attending ophthalmology clinics.

Authors:  A G Karseras; A H Crisp
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

  4 in total
  3 in total

Review 1.  Ophthalmology and general medicine.

Authors:  A Karseras
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

Review 2.  Hysterical symptoms in ophthalmology.

Authors:  M Weller; P Wiedemann
Journal:  Doc Ophthalmol       Date:  1989-09       Impact factor: 2.379

3.  Case reports on psychosomatic eye disorders.

Authors:  P Fenton
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.